IRIS Accounts Production v26.2.0.496 12599883 Board of Directors 1.6.25 31.5.26 31.5.26 false true false false true false 14000 4500 14000 14624 3876 14000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh125998832025-05-31125998832026-05-31125998832025-06-012026-05-31125998832024-05-31125998832024-06-012025-05-31125998832025-05-3112599883ns15:EnglandWales2025-06-012026-05-3112599883ns14:PoundSterling2025-06-012026-05-3112599883ns10:Director12025-06-012026-05-3112599883ns10:PrivateLimitedCompanyLtd2025-06-012026-05-3112599883ns10:SmallEntities2025-06-012026-05-3112599883ns10:AuditExempt-NoAccountantsReport2025-06-012026-05-3112599883ns10:SmallCompaniesRegimeForDirectorsReport2025-06-012026-05-3112599883ns10:SmallCompaniesRegimeForAccounts2025-06-012026-05-3112599883ns10:FullAccounts2025-06-012026-05-311259988342ns10:Director22025-05-311259988342ns10:Director22025-06-012026-05-311259988342ns10:Director22024-06-012025-05-311259988342ns10:Director22026-05-311259988342ns10:Director22025-05-3112599883ns10:Director22025-06-012026-05-3112599883ns10:RegisteredOffice2025-06-012026-05-3112599883ns5:CurrentFinancialInstruments2026-05-3112599883ns5:CurrentFinancialInstruments2025-05-3112599883ns5:ShareCapital2026-05-3112599883ns5:ShareCapital2025-05-3112599883ns5:RetainedEarningsAccumulatedLosses2026-05-3112599883ns5:RetainedEarningsAccumulatedLosses2025-05-3112599883ns5:MotorVehicles2025-06-012026-05-3112599883ns5:ComputerEquipment2025-06-012026-05-3112599883ns5:PlantMachinery2025-05-3112599883ns5:MotorVehicles2025-05-3112599883ns5:ComputerEquipment2025-05-3112599883ns5:PlantMachinery2025-06-012026-05-3112599883ns5:PlantMachinery2026-05-3112599883ns5:MotorVehicles2026-05-3112599883ns5:ComputerEquipment2026-05-3112599883ns5:PlantMachinery2025-05-3112599883ns5:MotorVehicles2025-05-3112599883ns5:ComputerEquipment2025-05-3112599883ns5:WithinOneYearns5:CurrentFinancialInstruments2026-05-3112599883ns5:WithinOneYearns5:CurrentFinancialInstruments2025-05-3112599883ns10:Director112025-05-3112599883ns10:Director112024-05-3112599883ns10:Director112025-06-012026-05-3112599883ns10:Director112024-06-012025-05-3112599883ns10:Director112026-05-3112599883ns10:Director112025-05-31
REGISTERED NUMBER: 12599883 (England and Wales)









DR CLARE SIEBER LTD

UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MAY 2026






DR CLARE SIEBER LTD (REGISTERED NUMBER: 12599883)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MAY 2026




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


DR CLARE SIEBER LTD

COMPANY INFORMATION
FOR THE YEAR ENDED 31 MAY 2026







DIRECTORS: Dr C R Sieber
B Cummins





REGISTERED OFFICE: 2 Woodgate Farm Cottages
Hook Lane
Aldingbourne
Chichester
West Sussex
PO20 3SR





REGISTERED NUMBER: 12599883 (England and Wales)





ACCOUNTANTS: Morris Crocker
Chartered Accountants
Lake House
2 Port Way
Port Solent
Portsmouth
Hampshire
PO6 4TY

DR CLARE SIEBER LTD (REGISTERED NUMBER: 12599883)

BALANCE SHEET
31 MAY 2026

2026 2025
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 13,350 16,252

CURRENT ASSETS
Debtors 5 15,012 19,545
Cash at bank 2,921 6,309
17,933 25,854
CREDITORS
Amounts falling due within one year 6 27,995 24,480
NET CURRENT (LIABILITIES)/ASSETS (10,062 ) 1,374
TOTAL ASSETS LESS CURRENT
LIABILITIES

3,288

17,626

PROVISIONS FOR LIABILITIES 3,097 4,063
NET ASSETS 191 13,563

CAPITAL AND RESERVES
Called up share capital 2 2
Retained earnings 189 13,561
SHAREHOLDERS' FUNDS 191 13,563

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 May 2026.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 May 2026 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 24 July 2026 and were signed on its behalf by:




Dr C R Sieber - Director


DR CLARE SIEBER LTD (REGISTERED NUMBER: 12599883)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MAY 2026

1. STATUTORY INFORMATION

Dr Clare Sieber Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Motor vehicles - 25% on reducing balance
Computer equipment - 33.33% on cost

Financial instruments
The company only enters into basic financial instruments transactions that result in the recognition of financial assets and liabilities like trade and other accounts receivable and payable, loans from banks and other third parties and loans to related parties and investments in non-puttable ordinary shares.

Trade and other debtors
Short term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment

Cash and cash equivalents
Cash and cash equivalents comprise cash at bank and on hand, deposits with banks and other short-term highly liquid investments and bank overdrafts. In the balance sheet, bank overdrafts are shown within borrowings or current liabilities.

Trade and other creditors
Short term trade creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


DR CLARE SIEBER LTD (REGISTERED NUMBER: 12599883)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MAY 2026

2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 3 (2025 - 3 ) .

4. TANGIBLE FIXED ASSETS
Plant and Motor Computer
machinery vehicles equipment Totals
£    £    £    £   
COST
At 1 June 2025 - 33,381 5,286 38,667
Additions 1,099 250 1,240 2,589
At 31 May 2026 1,099 33,631 6,526 41,256
DEPRECIATION
At 1 June 2025 - 19,298 3,117 22,415
Charge for year 275 3,584 1,632 5,491
At 31 May 2026 275 22,882 4,749 27,906
NET BOOK VALUE
At 31 May 2026 824 10,749 1,777 13,350
At 31 May 2025 - 14,083 2,169 16,252

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2026 2025
£    £   
Trade debtors 9,828 820
Other debtors 5,184 18,725
15,012 19,545

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2026 2025
£    £   
Taxation and social security 23,557 18,608
Other creditors 4,438 5,872
27,995 24,480

DR CLARE SIEBER LTD (REGISTERED NUMBER: 12599883)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MAY 2026

7. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 31 May 2026 and 31 May 2025:

2026 2025
£    £   
Dr C R Sieber and B Cummins
Balance outstanding at start of year 14,000 -
Amounts advanced 4,500 14,000
Amounts repaid (14,624 ) -
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 3,876 14,000